Mostrando 2 resultados de: 2
Filtros aplicados
Subtipo de publicación
Review(2)
Publisher
Maturitas(2)
Área temáticas
Enfermedades(2)
Farmacología y terapéutica(1)
Ginecología, obstetricia, pediatría, geriatría(1)
Área de conocimiento
Medicamento(1)
Año de Publicación
2017(2)
Origen
scopus(2)
Drug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis: EMAS position statement
ReviewAbstract: Background Bisphosphonates and denosumab are used extensively in the treatment of postmenopausal ostPalabras claves:Alendronate, Bisphosphonates, Denosumab, Drug holiday, Risedronate, Zoledronic acidAutores:Anagnostis P., Ceausu I., Depypere H., Faustino R. Pérez-López, Goulis D.G., Lambrinoudaki I., Mintziori G., Mueck A., Paschou S.A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Trémollieres F.A.Fuentes:scopusOsteoporosis management in patients with breast cancer: EMAS position statement
ReviewAbstract: Aromatase inhibitors (AIs) are the first-line recommended standard of care for postmenopausal estrogPalabras claves:adjuvant therapy, Aromatase inhibitors, Bisphosphonates, Breast Cancer, Denosumab, fractures, OSTEOPOROSIS, screeningAutores:Ceausu I., Depypere H., Faustino R. Pérez-López, Lambrinoudaki I., Mueck A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Trémollieres F.A., van der Schouw Y.T.Fuentes:scopus